No significant effect was reported in measures of functional autonomy, mood, and behavioral disorders
While effective for appetite control, this can also lead to trapped wind, abdominal swelling, and stomach discomfort, particularly in the first weeks of treatment
In 2017, liraglutide became the first GLP-1 receptor agonist approved by the FDA to reduce the risk of major adverse cardiovascular events in adults with type 2 diabetes and established cardiovascular disease, based on results from the LEADER trial
We show that local Ex4 injection leads to increased neuronal activation of MCs in the OB
Selecting acid-sensitive chemical bonds such as hydrazone, acetal, ketal according to release mechanism and stability requirements, designing linkers that balance stability in blood and rapid cleavage in acidic conditions
Clinical studies on Trulicity found that it reduced A1C by 1.3 to 1.6%